BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28073832)

  • 1. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.
    Toldo S; Mauro AG; Cutter Z; Van Tassell BW; Mezzaroma E; Del Buono MG; Prestamburgo A; Potere N; Abbate A
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):215-222. PubMed ID: 30747785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.
    Talukder MA; Yang F; Shimokawa H; Zweier JL
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H437-45. PubMed ID: 20525875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
    Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
    Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
    J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
    Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.
    Toldo S; Marchetti C; Mauro AG; Chojnacki J; Mezzaroma E; Carbone S; Zhang S; Van Tassell B; Salloum FN; Abbate A
    Int J Cardiol; 2016 Apr; 209():215-20. PubMed ID: 26896627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.
    Jones SP; Greer JJ; Kakkar AK; Ware PD; Turnage RH; Hicks M; van Haperen R; de Crom R; Kawashima S; Yokoyama M; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H276-82. PubMed ID: 12969888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.
    Baotic I; Ge ZD; Sedlic F; Coon A; Weihrauch D; Warltier DC; Kersten JR
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H219-27. PubMed ID: 23666677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition.
    Toldo S; Mauro AG; Marchetti C; Rose SW; Mezzaroma E; Van Tassell BW; Kim S; Dinarello CA; Abbate A
    J Cardiovasc Pharmacol; 2016 Jul; 68(1):27-32. PubMed ID: 26945157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture preconditioning attenuates acute myocardial ischemia injury through inhibiting NLRP3 inflammasome activation in mice.
    Zhang T; Yang WX; Wang YL; Yuan J; Qian Y; Sun QM; Yu ML; Fu SP; Xu B; Lu SF
    Life Sci; 2020 May; 248():117451. PubMed ID: 32088213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide Therapy Suppresses Cofilin-2 and Attenuates Ischemic Heart Failure in a Mouse Model of Myocardial Infarction.
    Nguyen K; Chau VQ; Mauro AG; Durrant D; Toldo S; Abbate A; Das A; Salloum FN
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):472-483. PubMed ID: 32390525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.
    Liu Q; Li Z; Liu Y; Xiao Q; Peng X; Chen Q; Deng R; Gao Z; Yu F; Zhang Y
    Cardiovasc Ther; 2018 Dec; 36(6):e12481. PubMed ID: 30597772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
    Shen S; He F; Cheng C; Xu B; Sheng J
    Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.